US2007128287A1PendingUtilityA1
Dermal composition for external use
Est. expiryAug 9, 2021(expired)· nominal 20-yr term from priority
A61K 31/618A61K 31/353A61K 47/18A61K 47/10A61K 9/0014A61K 47/36A61P 17/00A61K 47/06A61K 47/14
62
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The object of the present invention is to provide a dermal composition for external use which keeps skin healthy and demonstrates a sufficient effect in treating skin diseases. The present invention relates to a dermal composition for external use, which comprises sodium cromoglycate and a monoester of polyvalent alcohol and salicylic acid contained in a base.
Claims
exact text as granted — not AI-modified1 . A dermal composition for external use,
which comprises sodium cromoglycate and a monoester of polyvalent alcohol and salicylic acid contained in a base.
2 . The dermal composition for external use according to claim 1 ,
wherein the monoester of polyvalent alcohol and salicylic acid is glycol salicylate.
3 . The dermal composition for external use according to claim 1 wherein the content of the monoester of polyvalent alcohol and salicylic acid is 1 to 20% by weight.
4 . The dermal composition for external use according to claim 1 ,
wherein said dermal composition for external use contains at least one transcutaneous absorption enhancer selected from the group consisting of N-acyl sarcosine or a salt thereof, a higher fatty acid ester of a C10 to C18 higher fatty acid and a C1 to C20 alcohol, a C2 to C10 dicarboxylic acid or a salt thereof, a hydroxycarboxylic ester of a C3 to C6 hydroxycarboxylic acid and a C1 to C20 alcohol, a fatty acid ethanol amide, glycerin, propylene glycol, polyethylene glycol, urea, glycyrrhizinic acid, squalane and mucopolysaccharide.
5 . The dermal composition for external use according to claim 4 ,
wherein the transcutaneous absorption enhancer is at least one member selected from the group consisting of glycerin, propylene glycol, urea, squalane and mucopolysaccharide.
6 . The dermal composition for external use according to claim 1 ,
wherein the base is a water-soluble base.
7 . The dermal composition for external use according to claim 1 ,
wherein a pH value thereof is of 2 to 7.
8 . The dermal composition for external use according to claim 1 ,
wherein a pH value thereof is 4 to 5.
9 . A cosmetic,
which is obtainable by using the dermal composition for external use according to claim 1 .
10 . A pharmaceutical preparation,
which is obtainable by using the dermal composition for external use according to claim 1.Join the waitlist — get patent alerts
Track US2007128287A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.